tirzepatide surpass 4 Abstract 16779: Reduces High-Sensitivity C-reactive Protein in Patients With Type 2 Diabetes and High Cardiovascular Risk: A Post Hoc Analysis of the SURPASS-4 Trial Efficacy and safety of tirzepatide

FDA Restrictions on Compound GLP-1 Medications This regulatory action follows the FDA's February 2025 declaration that the semaglutide shortage is officially "resolved." For compounded tirzepatide (Zepbound), the deadline was earlier - March 2025

Pharmaceutical companies cant arbitrarily decide a medication should have a certain half-life

Ceramides: These lipid molecules support barrier function and help maintain skin hydration

Metabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFNgamma receptor signaling

Additional Resources: Multimedia is available on the right column of release link

ForYouths The Protect Glutathione+ combines 250 mg of glutathione with synergistic antioxidants for deeper: Cellular defense against oxidative stress Immune support Detoxification Discover The Protect - Glutathione+ - for youth